{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:30:58Z","timestamp":1786728658709,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Vasoplegic syndrome is a life-threatening condition characterized by uncontrolled peripheral vasodilation, leading to profound arterial hypotension. Treatments include catecholamines, vasopressin, methylene blue (MB), hydroxocobalamin, angiotensin II, and ascorbic acid. We developed a scoping review protocol according to the Joanna Briggs Institute methodology and searched PubMed, PubMed Central, Scopus, and Cochrane Library electronic databases. A total of 23 records were included in this scoping review, out of which 13 were original research studies, seven were reviews, and three were case studies. In these studies, vasopressin, MB, hydroxocobalamin, angiotensin II, and ascorbic acid were used for vasoplegic syndrome. Vasopressin, MB, hydroxocobalamin, angiotensin II, and ascorbic acid showed rapid restoration of hemodynamics and decreased vasopressor requirement. Non-catecholamine drugs such as vasopressin, angiotensin II, MB, and hydroxocobalamin appear to be promising drugs for the treatment of patients with post-cardiac surgery vasoplegic syndrome. It is demonstrated to be effective in raising blood pressure in such patients, but these agents should be used cautiously due to their associated adverse effects.<\/jats:p>","DOI":"10.4103\/aca.aca_86_25","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:00:10Z","timestamp":1768579210000},"page":"4-12","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Role of Non-catecholamines Vasopressors in the Management of Vasoplegic Syndrome after Cardiopulmonary Bypass: A Scoping Review"],"prefix":"10.4103","volume":"29","author":[{"given":"Amarjeet","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira","family":"Jayan","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakanksha","family":"Hiremath","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"R1-20260331","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"R2-20260331","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejcts.2008.07.012","article-title":"Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?","volume":"34","author":"Sun","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"R3-20260331","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"R4-20260331","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-20260331","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-20260331","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2044.2006.04779.x","article-title":"Association between vasopressor dependence and early outcome in patients after cardiac surgery","volume":"61","author":"Weis","year":"2006","journal-title":"Anaesthesia"},{"key":"R7-20260331","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/01.CCM.0000201005.34203.50","article-title":"Role of endogenous adenosineas a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response","volume":"34","author":"Kerbaul","year":"2006","journal-title":"Crit CareMed"},{"key":"R8-20260331","first-page":"532","article-title":"Incidence and predictors of vasoplegia after heart failure surgery","volume":"51","author":"Van Vessem","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"R9-20260331","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/j.jvca.2017.10.032","article-title":"Vasoplegia after cardiovascular procedures-pathophysiology and trageted therapy","volume":"32","author":"Shaefi","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R10-20260331","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s001340101014","article-title":"The effect of vasopressin on hemodynamics and renal function in severe septic shock: A case series","volume":"27","author":"Holmes","year":"2001","journal-title":"Intensive Care Med"},{"key":"R11-20260331","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.semnephrol.2019.06.006","article-title":"Vasopressor therapy and blood pressure management in the setting of acute kidney injury","volume":"39","author":"Buss","year":"2019","journal-title":"Semin Nephrol"},{"key":"R12-20260331","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1213\/ANE.0000000000001045","article-title":"Methylene blue: Magic bullet for vasoplegia?","volume":"122","author":"Hosseinian","year":"2016","journal-title":"Anesth Analg"},{"key":"R13-20260331","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia: A review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R14-20260331","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1213\/00000539-199503000-00007","article-title":"Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass","volume":"80","author":"Tuman","year":"1995","journal-title":"Anesth Analg"},{"key":"R15-20260331","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/jappl.2001.90.3.795","article-title":"Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat","volume":"90","author":"Armour","year":"2001","journal-title":"J Appl Physiol (1985)"},{"key":"R16-20260331","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"R17-20260331","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1213\/XAA.0000000000000752","article-title":"Vitamin C for vasoplegia after cardiopulmonary bypass: A case series","volume":"11","author":"Wieruszewski","year":"2018","journal-title":"A A Pract"},{"key":"R18-20260331","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II Is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R19-20260331","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/10600280221099928","article-title":"Evaluation of the addition of angiotensin II in patients with shock after cardiac surgery at a veterans affairs medical centre","volume":"57","author":"Bird","year":"2023","journal-title":"Ann Pharmacother"},{"key":"R20-20260331","first-page":"e0687","article-title":"Protocol compliance guiding angiotensin II use in post cardiovascular surgery vasoplegia","volume":"4","author":"Ten","year":"2022","journal-title":"Crit Care Explor"},{"key":"R21-20260331","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/aca.aca_98_21","article-title":"Outcomes following the use of angiotensin II patients with postoperative vasoplegic syndrome: A case series","volume":"25","author":"Konkol","year":"2022","journal-title":"Ann Card Anaesth"},{"key":"R22-20260331","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10557-020-07098-3","article-title":"The use of angiotensin II for the treatment of post cardiopulmonary bypass vasoplegia","volume":"36","author":"Papazisi","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"R23-20260331","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/CCM.0000000000006433","article-title":"Angiotensin-II and thromboembolic events: A systematic review","volume":"52","author":"Caragata","year":"2024","journal-title":"Crit Care Med"},{"key":"R24-20260331","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/anae.15802","article-title":"A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery","volume":"77","author":"Coulson","year":"2022","journal-title":"Anesthesia"},{"key":"R25-20260331","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/ANE.0000000000006839","article-title":"A pilot study of renin-guided angiotensin-II infusion to reduce kidney stress after cardiac surgery","volume":"139","author":"Sadjadi","year":"2024","journal-title":"Anesth Analg"},{"key":"R26-20260331","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/08850666221145864","article-title":"Angiotensin II for vasodilatory hypotension in patients requiring mechanical circulatory support","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J Intensive Care Med"},{"key":"R27-20260331","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13019-021-01579-8","article-title":"The additional use of methylene blue has a decatecholaministion effect on cardiac vasoplegic syndrome after cardiac surgery","volume":"16","author":"Petermichl","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"R28-20260331","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/aca.ACA_237_16","article-title":"Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study","volume":"20","author":"Mazzeffi","year":"2017","journal-title":"Ann Card Anaesth"},{"key":"R29-20260331","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/jcm11041121","article-title":"Early use of methylene blue in vasoplegic syndrome: A 10-year propensity score-matched cohort study","volume":"11","author":"Kofler","year":"2022","journal-title":"J Clin Med"},{"key":"R30-20260331","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac surgery: Early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"R31-20260331","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/ijccm.IJCCM_494_17","article-title":"Methylene blue for vasoplegic syndrome postcardiac surgery","volume":"22","author":"Habib","year":"2018","journal-title":"Indian J Crit Care Med"},{"key":"R32-20260331","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1532\/hsf.1806","article-title":"Methylene blue for vasoplegic syndrome","volume":"20","author":"Booth","year":"2017","journal-title":"Heart Surg Forum"},{"key":"R33-20260331","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1053\/j.jvca.2022.04.003","article-title":"Association of methylene blue dosing with hemodynamic response for the treatment of vasoplegia","volume":"36","author":"Hohlfelder","year":"2022","journal-title":"J Cardiothorac Vasc Anaesth"},{"key":"R34-20260331","first-page":"e28267","article-title":"High-dose hydroxocobalamin for refractory vasoplegia post cardiac surgery","volume":"14","author":"Bak","year":"2022","journal-title":"Cureus"},{"key":"R35-20260331","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1053\/j.jvca.2024.09.135","article-title":"Hydroxocobalamin versus methylene blue for treatment of vasoplegic shock following cardiopulmonary bypass: A systematic review and meta-analysis","volume":"38","author":"Cadd","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R36-20260331","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomised controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"R37-20260331","doi-asserted-by":"crossref","first-page":"e387523","DOI":"10.1590\/acb387523","article-title":"Vasopressin in vasoplegic shock in surgical patients: Systematic review and meta-analysis","volume":"8","author":"Szeles","year":"2023","journal-title":"Acta Cir Bras"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_86_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:30:01Z","timestamp":1786725001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_86_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_86_25","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-04-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}